Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
SOVUNA
Show more
Pharmaceutical preparations for the treatment of oncological and cardiovascular diseases, hypertension, renal disorders and arthritis; Pharmaceutical preparations for the treatment of infectious diseases and auto-immune diseases
Class 5 – Pharmaceuticals & supplements
Status timeline
- 27 Feb 2023Application filedNew Application Entered
- 16 Mar 2023Assigned to an examining attorneyAssigned To Examiner
- 16 Mar 2023Approved for publicationApproved For Pub - Principal Register
- 18 Apr 2023Published for oppositionPublished For Opposition
- 13 Jun 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 11 Dec 2023Statement-of-use extension 1 grantedSou Extension 1 Granted
- 3 Apr 2024Statement of use filedTeas Statement Of Use Received
- 24 Apr 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 28 May 2024Registered on the Principal RegisterRegistered-Principal Register
All 20 events
| 2024-05-28 | Registered-Principal Register |
| 2024-05-28 | Notice Of Registration Confirmation Emailed |
| 2024-04-24 | Case Assigned To Intent To Use Paralegal |
| 2024-04-24 | Statement Of Use Processing Complete |
| 2024-04-24 | Allowed Principal Register - Sou Accepted |
| 2024-04-24 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-04-03 | Teas Statement Of Use Received |
| 2024-04-03 | Use Amendment Filed |
| 2023-12-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-12-11 | Sou Teas Extension Received |
| 2023-12-11 | Sou Extension 1 Filed |
| 2023-12-11 | Sou Extension 1 Granted |
| 2023-06-13 | Noa Mailed - Sou Required From Applicant |
| 2023-04-18 | Published For Opposition |
| 2023-04-18 | Official Gazette Publication Confirmation E-Mailed |
| 2023-03-29 | Notification Of Notice Of Publication E-Mailed |
| 2023-03-16 | Assigned To Examiner |
| 2023-03-16 | Approved For Pub - Principal Register |
| 2023-03-14 | New Application Office Supplied Data Entered |
| 2023-02-27 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of oncological and cardiovascular diseases, hypertension, renal disorders and arthritis; Pharmaceutical preparations for the treatment of infectious diseases and auto-immune diseases
First use anywhere 4 Mar 2024 · First use in commerce 4 Mar 2024
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 28 May 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.